YOLFTbeta
67

iXensor Co., Ltd.

6734 · TWO · Healthcare / Medical Devices

5.30TWD+0.12 (+2.32%)

Price History

Full chart

Market Stats

Previous Close5.18
Open5.39
Day Range5.13 – 5.39
52-Week Range4.71 – 18.50
Volume34.10K
Market Cap230.47M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.25
Dividend Yield0.00%
Beta0.57
50-Day Avg6.04
200-Day Avg6.73

About

iXensor Co., Ltd. engages in the research, development, and manufacture of medical devices. It offers PixoTest Vision Analysis System and PixoHealth Vision application for chronic disease monitoring, as well as Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management. The company was founded in 2012 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Yanyu Chen Ph.D.
  • HeadquartersNo. 9, Alley 2, Lane 35, Taipei, Taiwan, 11492, Taiwan
  • Websitehttps://www.ixensor.com

Leadership

  • Dr. Yanyu Chen Ph.D.Co-Founder, Chairman, Manager & CEO
  • Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.Chief Advisor & Board Member · b. 1957
  • Dr. Alan Tsai Ph.D.Co-Founder & Project Advisor
  • Dr. Jerry Chen M.D., Ph.D.Co-Founder & Medical Advisor
  • Shulan HuangAccounting Supervisor

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue30.03M15.92M24.79M105.23M20.89M19.46M26.88M
Growth (%)--46.98%+55.70%+324.44%-80.15%-6.85%+38.14%
Cost of Revenue21.00M11.42M20.17M42.63M19.29M13.46M9.98M
Gross Profit9.03M4.50M4.62M62.60M1.60M6.00M16.91M
Gross Margin30.06%28.28%18.63%59.49%7.65%30.83%62.89%
Operating Expense118.07M84.53M86.10M67.83M64.64M52.09M62.62M
Operating Income-109.04M-80.03M-81.48M-5.23M-63.04M-46.09M-45.71M
Operating Margin-363.07%-502.56%-328.63%-4.97%-301.77%-236.83%-170.06%
EBITDA-96.68M-65.60M-64.33M2.39M-56.76M-39.32M-39.63M
EBITDA Margin-321.93%-411.98%-259.46%2.27%-271.70%-202.06%-147.42%
Net Income-104.65M-76.61M-73.08M-4.89M-63.19M-46.81M-46.96M
Net Income Margin-348.47%-481.12%-294.75%-4.65%-302.51%-240.55%-174.69%
R&D42.35M36.05M47.08M28.04M26.24M25.97M27.21M
R&D as % of Total Revenue141.02%226.41%189.87%26.65%125.63%133.46%101.22%
Interest Expense177.00K127.00K48.00K150.00K492.00K1.32M1.33M
Interest Expense % of Total Revenue0.59%0.80%0.19%0.14%2.36%6.80%4.97%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets179.35M97.45M73.58M104.72M96.38M74.62M68.97M
Total Liabilities25.80M18.36M16.59M24.03M63.65M64.56M45.88M
Total Equity153.55M79.09M56.99M80.69M32.73M10.05M23.09M
Cash66.28M34.85M13.76M46.20M47.40M37.11M38.26M
Total Debt10.67M6.16M1.67M16.74M52.51M58.93M-
Net Debt-55.61M-28.69M-12.09M-29.46M5.11M817.00K-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-96.99M-57.15M-71.96M8.12M-46.20M-40.33M-36.91M
Investing Cash Flow46.18M28.14M4.26M-680.00K-2.93M-1.68M-
Financing Cash Flow11.01M-2.42M46.61M24.89M50.31M31.68M-
Capital Expenditure1.54M1.85M1.58M745.00K1.75M1.07M378.00K
Free Cash Flow-98.53M-59.00M-73.53M7.37M-47.95M-40.89M-37.29M
FCF to OCF101.59%103.24%102.19%90.82%103.79%101.38%101.02%

Key Statistics & Ratios

Market Cap230.47M
Enterprise Value222.90M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.64
Price / Book25.14
EPS-1.25
Book Value0.211
Revenue (TTM)26.67M
Gross Profit (TTM)16.11M
EBITDA-46.16M
Profit Margin-184.11%
Operating Margin-226.49%
Return on Equity-283.37%
Return on Assets-66.66%
Shares Outstanding41.53M
Shares Float25.64M
Beta0.57
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 22, 2024400:1000